Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas James Doyle currently holds 142,428 shares of Kura Oncology, Inc. (KURA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas James Doyle has been a net seller of KURA stock. They have purchased $0 and sold $202.5K worth of shares.
Thomas James Doyle's most recent insider trade was on Sep 28, 2026, when they sold 4,607 shares at $10.50 per share.
Thomas James Doyle serves as Executive at Kura Oncology, Inc. (KURA). They have executed 16 insider transactions totaling $202.5K over their tenure at the company.
Thomas James Doyle holds the position of Executive at Kura Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Thomas James Doyle has shown a selling trading pattern, with $0 in total purchases and $202.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas James Doyle was on Nov 14, 2025, when they sold $50.7K worth of KURA shares. This transaction involved 4,539 shares at $11.18 per share.
Thomas James Doyle currently owns 142,428 shares of Kura Oncology, Inc. (KURA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas James Doyle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas James Doyle has 16 Form 4 filings on record as an insider at Kura Oncology, Inc..
Set alerts for Thomas James Doyle and 40,000+ other insiders.